Basil Pharma Intel - Medical Affairs Intelligence

Basil Pharma Intel - Medical Affairs Intelligence is an AI-powered platform designed for Medical Affairs teams in pharmaceutical and life sciences organizations. It provides a unified view of product safety, competitive efficacy, and clinical landscape data, supporting functions including KOL engagement, evidence generation, and structured collaboration with Commercial partners.

The platform is built around role-based access controls and audit trails that maintain regulatory compliance while allowing Medical and Commercial teams to share validated scientific intelligence within a single environment.

Competitive Safety Intelligence

• Monitors adverse events and performs comparative safety analysis across a company's own products and the competitive landscape.
• Provides real-time signal detection using AI-powered threshold analysis to identify emerging safety signals before they become public issues.
• Generates comparative safety profiles for use in KOL discussions, publication planning, and regulatory conversations.
• Supports evidence-based scientific narratives with proactive safety positioning.

Clinical Trial Landscape Monitoring

• Tracks global clinical trials with filtering options by phase, sponsor, endpoints, inclusion/exclusion criteria, and therapeutic area.
• Cross-references trial data directly against approved label claims.
• Covers more than 30 years of historical clinical trial data with hourly updates, surfacing competitive trials at the point of registration rather than at publication.
• Informs investigator-initiated trial design and publication strategies with full market context.

Compliant Medical-Commercial Collaboration

• Uses role-based access controls to maintain the regulatory firewall between Medical Affairs and Commercial functions.
• Medical Affairs generates scientifically rigorous insights; Commercial teams receive validated, compliance-appropriate intelligence.
• All activity is recorded with full audit trails to support compliance requirements.
• Structured insight sharing is enabled without requiring separate systems or manual compliance reviews.

KOL and Advisory Board Support

• Assembles evidence packages combining label data, clinical trial results, and safety profiles for Key Opinion Leader discussions, advisory boards, and congress engagements.
• Generates comprehensive briefing documents in minutes, ensuring Medical Science Liaison conversations are grounded in the latest validated data.
• Supports peer-to-peer scientific dialogue with physicians using authoritative, up-to-date evidence.

Workflow Example: Competitive Safety Analysis

1. A Medical Affairs team identifies the need for comparative safety data ahead of an advisory board with oncologists.
2. Rather than conducting manual FAERS queries and literature reviews over several weeks, the team uses Basil to generate validated comparative safety profiles across five competitor products.
3. The analysis, including demographic filtering and signal source references, is completed in under two minutes.

Deployment and Implementation

• Designed for implementation in under one hour, with minimal IT overhead and no extended deployment cycles.
• Covers use cases across Commercial, Regulatory, Medical Affairs, Quality, and Safety functions for both Pharma and MedTech organizations.
• Available as part of a broader Basil Systems platform that includes Commercial and Competitive Intelligence, Labeling and Regulatory, and Quality and Safety modules.

Basil Pharma Intel is positioned for pharmaceutical organizations seeking to consolidate safety analytics, clinical landscape monitoring, and Medical-Commercial collaboration into a single compliant platform, with a focus on rapid deployment and audit-ready data sharing.